254 related articles for article (PubMed ID: 17190795)
1. The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1.
Liao YC; Si L; deVere White RW; Lo SH
J Cell Biol; 2007 Jan; 176(1):43-9. PubMed ID: 17190795
[TBL] [Abstract][Full Text] [Related]
2. Cten, a COOH-terminal tensin-like protein with prostate restricted expression, is down-regulated in prostate cancer.
Lo SH; Lo TB
Cancer Res; 2002 Aug; 62(15):4217-21. PubMed ID: 12154022
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the focal adhesion targeting region of deleted in liver cancer-1 attenuate their expression and function.
Liao YC; Shih YP; Lo SH
Cancer Res; 2008 Oct; 68(19):7718-22. PubMed ID: 18829524
[TBL] [Abstract][Full Text] [Related]
4. Identification of subcellular targeting sequences of Cten reveals its role in cell proliferation.
Hong SY; Shih YP; Lo A; Lo SH
Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):450-458. PubMed ID: 30321615
[TBL] [Abstract][Full Text] [Related]
5. Solution structure of tensin2 SH2 domain and its phosphotyrosine-independent interaction with DLC-1.
Dai K; Liao S; Zhang J; Zhang X; Tu X
PLoS One; 2011; 6(7):e21965. PubMed ID: 21765928
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities.
Qian X; Li G; Asmussen HK; Asnaghi L; Vass WC; Braverman R; Yamada KM; Popescu NC; Papageorge AG; Lowy DR
Proc Natl Acad Sci U S A; 2007 May; 104(21):9012-7. PubMed ID: 17517630
[TBL] [Abstract][Full Text] [Related]
7. Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function.
Chan LK; Ko FC; Ng IO; Yam JW
PLoS One; 2009; 4(5):e5572. PubMed ID: 19440389
[TBL] [Abstract][Full Text] [Related]
8. Cleavage of cten by caspase-3 during apoptosis.
Lo SS; Lo SH; Lo SH
Oncogene; 2005 Jun; 24(26):4311-4. PubMed ID: 15806167
[TBL] [Abstract][Full Text] [Related]
9. Regulation of tensin-promoted cell migration by its focal adhesion binding and Src homology domain 2.
Chen H; Lo SH
Biochem J; 2003 Mar; 370(Pt 3):1039-45. PubMed ID: 12495434
[TBL] [Abstract][Full Text] [Related]
10. Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver.
Liao YC; Lo SH
Int J Biochem Cell Biol; 2008; 40(5):843-7. PubMed ID: 17521951
[TBL] [Abstract][Full Text] [Related]
11. C-terminal tensin-like (CTEN): a promising biomarker and target for cancer.
Lo SH
Int J Biochem Cell Biol; 2014 Jun; 51():150-4. PubMed ID: 24735711
[TBL] [Abstract][Full Text] [Related]
12. Tensin.
Lo SH
Int J Biochem Cell Biol; 2004 Jan; 36(1):31-4. PubMed ID: 14592531
[TBL] [Abstract][Full Text] [Related]
13. ΔNp63α Transcriptionally Regulates the Expression of CTEN That Is Associated with Prostate Cell Adhesion.
Yang K; Wu WM; Chen YC; Lo SH; Liao YC
PLoS One; 2016; 11(1):e0147542. PubMed ID: 26784942
[TBL] [Abstract][Full Text] [Related]
14. Tensins are versatile regulators of Rho GTPase signalling and cell adhesion.
Blangy A
Biol Cell; 2017 Mar; 109(3):115-126. PubMed ID: 27748980
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of the activity of deleted in liver cancer 1 (DLC1) by tensins controls cell migration and transformation.
Cao X; Voss C; Zhao B; Kaneko T; Li SS
Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1455-60. PubMed ID: 22307599
[TBL] [Abstract][Full Text] [Related]
16. CTEN prolongs signaling by EGFR through reducing its ligand-induced degradation.
Hong SY; Shih YP; Li T; Carraway KL; Lo SH
Cancer Res; 2013 Aug; 73(16):5266-76. PubMed ID: 23774213
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of the phosphotyrosine binding (PTB) domain of human tensin2 protein in complex with deleted in liver cancer 1 (DLC1) peptide reveals a novel peptide binding mode.
Chen L; Liu C; Ko FC; Xu N; Ng IO; Yam JW; Zhu G
J Biol Chem; 2012 Jul; 287(31):26104-14. PubMed ID: 22645138
[TBL] [Abstract][Full Text] [Related]
18. High-throughput phosphotyrosine profiling using SH2 domains.
Machida K; Thompson CM; Dierck K; Jablonowski K; Kärkkäinen S; Liu B; Zhang H; Nash PD; Newman DK; Nollau P; Pawson T; Renkema GH; Saksela K; Schiller MR; Shin DG; Mayer BJ
Mol Cell; 2007 Jun; 26(6):899-915. PubMed ID: 17588523
[TBL] [Abstract][Full Text] [Related]
19. Individual domains of Tensin2 exhibit distinct subcellular localisations and migratory effects.
Hafizi S; Sernstad E; Swinny JD; Gomez MF; Dahlbäck B
Int J Biochem Cell Biol; 2010 Jan; 42(1):52-61. PubMed ID: 19747564
[TBL] [Abstract][Full Text] [Related]
20. Focal adhesion kinase tyrosine-861 is a major site of phosphorylation by Src.
Calalb MB; Zhang X; Polte TR; Hanks SK
Biochem Biophys Res Commun; 1996 Nov; 228(3):662-8. PubMed ID: 8941336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
